Search Results - "Öztürk, Cemaleddin"
-
1
Eltrombopag for the Treatment of Poor Graft Function Following Haematopoietic Cell Transplantation: Real-Life Data
Published in Balkan medical journal (01-01-2023)“…Eltrombopag has an off-label indication for haematopoietic cell transplantation in patients experiencing delayed thrombocyte recovery and/or thrombocytopaenia…”
Get full text
Journal Article -
2
Severe Bone Marrow Hypoplasia with Black Cumin (Nigella sativa) Ingestion in a Patient with T-ALL in First Complete Remission
Published in Turkish journal of haematology (01-01-2019)“…Nigella sativa L., commonly known as black cumin, black seed, or black caraway, contains the active component thymoquinone and has a historically extensive…”
Get full text
Journal Article -
3
Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors
Published in Turkish journal of haematology (01-01-2021)“…Objective: The optimal timing of measurable residual disease (MRD) evaluation in acute myeloid leukemia (AML) patients has not been well defined yet. We aimed…”
Get full text
Journal Article -
4
-
5
Phenotypes of BONE Marrow Monocytes in STEM Cell Transplantation for ACUTE Leukemia: A Descriptive PILOT Study
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article -
6
Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article -
7
458 - Phenotypes of BONE Marrow Monocytes in STEM Cell Transplantation for ACUTE Leukemia: A Descriptive PILOT Study
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article -
8
340 - Is It Safe to Continue Allogeneic Hematopoietic Cell Transplantation Via Cryopreservation during COVID-19 Pandemic?
Published in Transplantation and cellular therapy (01-03-2022)Get full text
Journal Article -
9
Highlighting the Prognostic Importance of Measurable Residual Disease Amongst Acute Myeloid Leukemia Risk Factors
Published in Turkish journal of haematology (28-10-2020)“…The optimal timing of measurable residual disease (MRD) evaluation in acute myeloid leukemia (AML) patients has not been well-defined yet. We aimed to…”
Get full text
Journal Article -
10
-
11
A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in patients with myeloproliferative neoplasm
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e19536 Background: Pegylated forms of interferon (PEG-IFN) have a better pharmacologic profile than short-acting interferons, resulting in a more…”
Get full text
Journal Article -
12
Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival
Published in Blood (29-11-2018)“…Introduction:High-dose Melphalan followed by autologous hematopoietic cell transplantation (ASCT) compared to conventional chemotherapies has been shown to…”
Get full text
Journal Article -
13
SEVERE BONE MARROW HYPOPLASIA WITH BLACK CUMIN (N Sativa) INGESTION IN A PATIENT WITH T-ALL IN COMPLETE REMISION -1
Published in Turkish journal of haematology (11-06-2019)Get full text
Journal Article -
14